CNBCTV1813h
India sees limited impact of US tariffs on pharma sector, eyes larger share in global exports: Sources
India expects minimal price changes for its pharma exports under new US tariffs, as punitive measures haven’t hit the sector ...
Trump tariff hunt eyes India's last stock market refuge but it won't be an easy kill
Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...
Trump drops pharma tariff bombshell: Is India’s $50 billion drug industry in trouble? Challenges & the way forward
Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...
India's generic medicines steal the spotlight as US exempts pharma from tariffs
The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their ...
Pharma, jewellery and garments… India’s big winners and losers after Trump’s ‘Liberation Day’ tariffs
US President Donald Trump has imposed a country-level tariff of 27 per cent on exports from India as part of his ‘Liberation ...
From Pharma Gains to Jewellery Pain: India’s Mixed Reaction to U.S. Tariffs
India grapples with the impact of U.S. tariffs, affecting industries like jewellery and automotive while seeking strategic ...
IndiaWest2d
26% Tariff: Trump’s Reciprocal Target Against Indian Exports, Pharma Spared For Now
WASHINGTON, DC – U.S. President Donald Trump on April 2 announced a sweeping 26% “reciprocal tariff” on Indian imports, ...
Pharma companies escape bitter pill, for now
The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export ...
India emerges winner in US reciprocal tariff, sees limited impact of pharma tariffs
India emerges stronger in the US-India reciprocal tariffs scenario, negotiating favorable trade agreements and protecting ...